Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 202150

Expand all

MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDE)
12.5MG;7.5MG
Marketing Status: Discontinued

Active Ingredient: HYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDE
Proprietary Name: MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 12.5MG;7.5MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A202150
Product Number: 001
Approval Date: Mar 7, 2014
Applicant Holder Full Name: HERITAGE PHARMACEUTICALS INC DBA AVET PHARMACEUTICALS INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDE)
12.5MG;15MG
Marketing Status: Discontinued

Active Ingredient: HYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDE
Proprietary Name: MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 12.5MG;15MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A202150
Product Number: 002
Approval Date: Mar 7, 2014
Applicant Holder Full Name: HERITAGE PHARMACEUTICALS INC DBA AVET PHARMACEUTICALS INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDE)
25MG;15MG
Marketing Status: Discontinued

Active Ingredient: HYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDE
Proprietary Name: MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 25MG;15MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A202150
Product Number: 003
Approval Date: Mar 7, 2014
Applicant Holder Full Name: HERITAGE PHARMACEUTICALS INC DBA AVET PHARMACEUTICALS INC
Marketing Status:  Discontinued
Patent and Exclusivity Information